To assess the efficacy of oral cannabis extract for pain management in cancer patients undergoing cancer directed treatment
Phase 2
- Conditions
- Health Condition 1: C801- Malignant (primary) neoplasm, unspecified
- Registration Number
- CTRI/2024/06/068682
- Lead Sponsor
- Whole leaf Organics Pvt Ltd
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Adult patients
Histopathologically confirmed cancer diagnosis
Moderate or severe pain
Stable regime of pain management inclusive of NSAIDS weak opioid opioids
Palliative intent therapy
Exclusion Criteria
Major psychiatric disorder
Cardiovascular disorder
Epilepsy
Significant renal or hepatic impairment
Pregnancy
Lactating Women
Patients who were currently using or had used cannabinoid based medications within 30
days of study entry
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method